Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
11 hedge funds and large institutions have $355K invested in Petros Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
15% less funds holding
Funds holding: 13 → 11 (-2)
36% less capital invested
Capital invested by funds: $558K → $355K (-$203K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
71% less call options, than puts
Call options by funds: $24K | Put options by funds: $83K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$99.3K |
| 2 |
Jane Street
New York
|
+$23.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$11.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$52.6K |
| 2 |
VF
Virtu Financial
New York
|
-$44K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$16.9K |
| 4 |
V
Veritable
Wilmington,
Delaware
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $131K | +$99.3K | +547 | +115% |
|
2
BlackRock
New York
| $84K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $45K | +$11.4K | +63 | +22% |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $39K | +$1.09K | +6 | +2% |
|
5
State Street
Boston,
Massachusetts
| $23K | – | – | – |
|
|
6
Jane Street
New York
| $17K | +$23.8K | +131 | New |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $9K | -$52.6K | -290 | -80% |
|
|
EL
8
EMFO LLC
Weston,
Florida
| $5K | – | – | – |
|
|
NFSG
9
Newbridge Financial Services Group
Boca Raton,
Florida
| $1K | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
VF
11
Virtu Financial
New York
| – | -$44K | -214 | Closed |
|
|
12
Simplex Trading
Chicago,
Illinois
| – | -$16.9K | -93 | Closed |
|
|
V
13
Veritable
Wilmington,
Delaware
| – | -$14K | -67 | Closed |
|
PTPI Hedge Fund Activity: Q3 2022 in Review
11 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q3 2022, worth a combined $355K — down 36% from $558K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PTPI and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $99.3K. The largest seller was Susquehanna International Group, cutting an estimated $52.6K.
- 11 institutional investors held Petros Pharmaceuticals (PTPI) as of Q3 2022, down from 13 in Q2 2022.
- Funds reported $355K of Petros Pharmaceuticals stock for Q3 2022, down 36% quarter-over-quarter.
- 1 fund opened new Petros Pharmaceuticals positions in Q3 2022 and 3 closed out, a net change of -2 holders.
- The largest Petros Pharmaceuticals buyer in Q3 2022 was Vanguard Group, an estimated $99.3K added.
- The largest Petros Pharmaceuticals seller in Q3 2022 was Susquehanna International Group, an estimated $52.6K sold.
Based on aggregated 13F filings for Q3 2022.